GENEVA, Sept. 7 -- ASHIBIO, INC. filed a patent application (US2026/016811) for “USE OF A FRIZZLED RECEPTOR POLYPEPTIDE FOR THE TREATMENT OF METABOLIC BONE DISEASES”. With publication no. WO/2026/183314, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 38/17
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....